LECOM Health

Alzheimer’s Disease

Search for a Provider, Specialty, Service or Location

LECOM Health Corry Memorial Hospital First Facility in Region to Offer Advanced Neurology PET CT Imaging to Diagnose Dementia

CORRY, Pa. (December 16, 2025) — LECOM Health Corry Memorial Hospital has successfully launched a Positron Emission Tomography and Computed Tomography (PET/CT) Amyloid imaging program in partnership with Vantage Mobile Services to assist in the diagnostic assessment of cognitive impairment. CMH is the first of Vantage’s facilities to offer advanced neurology PET CT imaging. A Neuraceq® amyloid PET scan is a type of medical brain imaging approved by the U.S. Food and Drug Administration. Doctors...Read More »

LECOM Health is First in the Region to Provide Amyloid-Targeting Therapies to Treat Alzheimer’s Disease

FDA-approved treatments administered as intravenous infusions Erie, Pa. (March 18, 2025) — LECOM Health is the first healthcare provider in the Erie region to offer amyloid-targeting therapies (ATT), which are monoclonal antibodies aimed at the amyloid-beta cascade for the treatment of early symptomatic Alzheimer’s Disease. FDA-approved medications being administered are Leqembi and Kisunla, which target the biomarkers related to AD and potentially slow the decline of the disease. Medication is administered as a 30-minute to...Read More »